Perrigo receives FDA approval for Desoximetasone Gel, generic version of Topicort

By Lisa Kerner

Erie, Pa., Jan. 10 - The Perrigo Co. said it has received approval from the U.S. Food and Drug Administration to manufacture and market Desoximetasone Gel USP, 0.05%.

The product is the AB-rated equivalent to Taro Pharmaceutical's Topicort Gel, 0.05%, indicated for the relief of inflammatory skin conditions.

The Perrigo Co. is manufacturer of over-the-counter pharmaceutical and nutritional products for the store brand market, as well as prescription generic drugs, active pharmaceutical ingredients and consumer products. The company is based in Allegan, Mich.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.